NextGen Biomed 2025
Let’s connect at NextGen Biomed 2025 in London to discuss how our CDMO and CRO solutions support biotech companies of all sizes and stages in advancing their life-changing treatments.
March 12-14, 2025 | London, United Kingdom | Booth #25
About NextGen Biomed 2025
NextGen Biomed offers a meeting space for experts in biologics and immunotherapy. Over three immersive days, attendees will explore the latest innovations in:
- Antibodies, enzymes, and complex molecules like ADCs
- Sustainability in the development of biologics
- Single-use technology
- Immunotherapy and immuno-oncology
- Vaccines
The event will also showcase advancements in biologics research and development, therapeutic optimization, vaccine development, and sustainable manufacturing.
Event details
Date: March 12-14, 2025
Format: In-person
Location: London, United Kingdom
Booth number: #25
Event website: NextGen Biomed 2025
Why Thermo Fisher Scientific?
Thermo Fisher Scientific provides comprehensive bioprocessing, CDMO, and CRO capabilities for biotechnology and pharma companies looking to advance their life-changing treatments. From early-phase/pre-IND stages to commercial-scale production, our end-to-end, integrated drug development, manufacturing, and research services set the industry standard.
As a trusted drug development partner, we help biotechnology companies meet key milestones with flexibility, innovative and reliable technology, and sustainable solutions, all while reducing risks. Our single-use technology and bioreactors—offering cost-effective and agile scale-up at 2,000 L, 5,000 L, or through multiplexing—further differentiate us from the competition.
Explore our new Path to IND for biologics platform
Thermo Fisher Scientific’s newly launched Path to IND for biologics platform is a comprehensive solution designed to accelerate biologics development for drug sponsors.
This innovative service combines advanced technologies and expert guidance to streamline the path from discovery to clinic, helping ensure your biologics reach patients faster.
Leveraging the robust and reliable CHO-K1 cell line, we can deliver up to 8 g/L of molecule with a nine-month turnaround time, plus clinical trial services as a three-month add-on.
Stop by booth #25 to learn more about Path to IND for biologics.
Meet our industry-leading expert, Dr. Elena Gontarz
Dr. Elena Gontarz, head of the scientific and technical affairs team at Thermo Fisher Scientific, led the development of our Path to IND for biologics platform. She’d love to discuss our newly launched approach, as well as our comprehensive bioprocessing, CDMO, and CRO capabilities for large molecule drugs.
Schedule a 1:1 meeting with Dr. Gontarz during the conference to gain industry-leading insights into the biologics sector and learn how our services and solutions, including our bioprocessing center of excellence for cell line development through downstream processing, can help you bring your biologic to market.
Attend Dr. Elena Gontarz’s presentation on March 14
Stream: Downstream Development Protein Purification & Recombinant Protein Production
Title: Path to IND for biologics: Ready for Phase I in 12 Months
Date: Friday, March 14, 2025
Time: 9:25 a.m. – 9:45 a.m. (20 minutes)
Summary: Join Thermo Fisher Scientific to explore a groundbreaking approach to biologics development and scale-up. Our next-generation platform streamlines transfection to IND-ready drug product in as few as nine months, with Phase I clinical supply and services ready in as few as three more. Learn how to de-risk and accelerate your program by attending this presentation.
Expert bio: Dr. Elena Gontarz , Ph.D. in biochemistry, has over 10 years of experience in biologics development. Currently, she is the head of our scientific and technical affairs team, leading CMC support and biologics programs from Phase I to commercial manufacturing. She is also our resident expert in global analytical and process development, as well as formulation sciences.
Be one of the first 25 visitors at booth #25 every day
For extra fun, we’ll be awarding company swag to the first 25 people who visit our booth every day.
Simply stop by booth #25 and ask if you made the cut. Our team can’t wait to see you in London!
To schedule a 1:1 meeting with our team during NextGen Biomed 2025, click the button below:
Continuing education for the pharma industry
Follow us on social for event updates
We look forward to seeing you soon